Christine Dolan, SVP - Product Development at Catalent, Inc. (CTLT), sold 745 shares at $34.85 ($26K) on 2017-08-01, disclosed to the SEC on 2017-08-03.
Scheduled sale ($26k) by SVP - Product Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.